🔍 Can we harness the power of cannabinoids while avoiding central side effects?. 🧠 FP05 – Synthesis and Immunological Profiling of Peripherally Restricted Compounds Based on the Cannabinoid Ligand WIN55,212-2. #SEQT_YRS2025 #Cannabinoid #Symposium @SocEspQuimTerap

🟠 Today, our PhD student Patricia García will present key findings of her research in a Flash Poster Presentation (FP-05) at the XI Symposium of Medicinal Chemistry Young Researchers. 🗓 July 18, 2025.📍Bilbao, Spain

👏🏼 Huge congratulations to our PhD student for receiving one of the SEQT Awards to attend the EFMC-certified Summer School! 🏅. Today, she presented her thesis work at this Summer School during a flash presentation. @SocEspQuimTerap #IXSummerSchool2025

🟠 Our PhD student Patricia García is attending the IX SEQT Summer School — a great opportunity to grow and connect. 🗓 July 15-17, 2025.📍Bilbao, Spain

RT @SocEspQuimTerap: 📯Awards for Early-Career Researchers in the Field of the Discovery and Development of Novel Therapies. • Andrea Bertra….

RT @SocEspQuimTerap: @EuOpenscreen @Teresa591543550 @JNJNews @andreabertran_ Now, Anabel Sánchez Merino awarded with Lilly Prize. https://t….

RT @SocEspQuimTerap: @EuOpenscreen Now FC12 by Daniel Fernández.

🧪 Curious about how we use chemical probes in our research? Come find us at P32 and let's talk science!.🔍 We'd love to share what we're working on!. P32 | Development of Chemical Probes for the identification of relevant target proteins in the immune system.@SocEspQuimTerap

🔬 PROTACs? Progeria?.Curious? Come find us at P7 and learn more about our research!.🧬 We’d love to chat!. P7 | Discovery of Novel Progerin Ligands for PROTAC-based Progeria Treatment.@SocEspQuimTerap #XXISEQT #Progeria

A great start to the conference: part of our group attended the first sessions, and our colleague Dra. Anabel Sánchez received the Lilly Award from the XXII SEQT Awards Call. We couldn't be prouder! 👏✨.@SocEspQuimTerap #LillyAward #MedicinalChemistry #Science

🟠 We are at the XXI National Meeting of the Spanish Society of Medicinal Chemistry!. 🗓 June 15-18, 2025.📍Sevilla, Spain

RT @SocEspQuimTerap: MedChemLab @MedChemLab_ucm .📌 Enfermedad rara: Progeria.🔍 Desarrollo de estrategias para reducir los niveles de proger….

RT @TortosaLab: Fantastic job from PhD students Pablo and Irene and huge collaborative effort with @isra_group @MedChemLab_ucm @alvarosomo….

RT @TortosaLab: Out @NatureChemistry our synthesis and validation of enantioenriched benzene bioisosteres! A milestone in our group led by….

RT @UCM_OrgChem: Today is #11F #InternationalDayOfWomenAndGirlsInScience! .A day to celebrate and encourage the achievements of #WomenInSci….

🤯Don't miss the opportunity to stop by the PO52 poster at 13 o'clock today!. 🧘🏽‍♀️Our PhD student Verónica Muñoz will present her magnificent work: CANNABINOID-BASED CHEMICAL PROBES FOR THE IDENTIFICATION OF RELEVANT THERAPEUTIC TARGETS IN THE IMMUNE SYSTEM. #EFMCISCB @EuroMedChem

Very proud of our former PhD student, Jon Macicior, now at @UoDCeTPD, for the Best Thesis Award in Rare Diseases, awarded by the Chair of Rare Diseases of the University of Almeria @ualmeria. Congratulations!!

🟠 Our PhD student Verónica muñoz is in the 2nd International Symposium on Chemical Biology (EFMC-ISCB)!. 🗓 January 29-31, 2025.📍Basel, Switzerland

Enjoying the group's Christmas lunch 🤶🎄. We are closing a year of a lot of science that has allowed us to publish some of the work carried out in the group. With this photo we wish you a Merry Christmas and a Happy New Year.

Congratulations to our present and former members of our lab for this nice work on the development of honokiol-derived chemical probes for target identification!!. 🔗